Addressing the surging problem of antimicrobial resistance

There is a growing problem with the prevalence of antibiotic-resistant pathogens, with a wide range of current and potential consequences that include increased mortality from infections and a reduction in non-emergency surgical procedures.

M3 is identical to an existing physiologic substance produced by the white blood cells and can be applied to the epithelial layer, whether topically or via a nebuliser. With hundreds of points of attack, it destroys the DNA, its enzymes, coating and toxins of bacteria, viruses and fungi, representing a paradigm-shift when compared to current treatment approaches. Resistance does not occur.